ICCC (STOCKS)
Immucell Corp
$10.550000
-0.430000 (-3.92%)
Prev close: $10.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul Olivier te Boekhorst
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $99.61M
- Employees
- 76
- P/E (TTM)
- -182.39
- P/B (TTM)
- 3.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $29.93M |
| Benefits Costs and Expenses | $30.46M |
| Cost Of Revenue | $17.19M |
| Costs And Expenses | $30.46M |
| Gross Profit | $12.75M |
| Nonoperating Income/Loss | -$3.02M |
| Operating Expenses | $10.25M |
| Research and Development | $2.60M |
| Other Operating Expenses | $7.64M |
| Operating Income/Loss | $2.50M |
| Income/Loss From Continuing Operations After Tax | -$545.40K |
| Income/Loss From Continuing Operations Before Tax | -$523.22K |
| Income Tax Expense/Benefit | $22.19K |
| Net Income/Loss | -$545.40K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$545.40K |
| Net Income/Loss Available To Common Stockholders, Basic | -$545.40K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 27,129,756 |
| Diluted Average Shares | 27,129,756 |
| Assets | $44.11M |
| Current Assets | $18.86M |
| Inventory | $8.67M |
| Prepaid Expenses | $647.49K |
| Other Current Assets | $9.54M |
| Noncurrent Assets | $25.25M |
| Fixed Assets | $20.78M |
| Other Non-current Assets | $4.47M |
| Liabilities | $14.97M |
| Current Liabilities | $3.91M |
| Noncurrent Liabilities | $11.06M |
| Long-term Debt | $8.70M |
| Other Non-current Liabilities | $2.36M |
| Equity | $29.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.14M |
| Liabilities And Equity | $44.11M |
| Net Cash Flow From Operating Activities | $4.47M |
| Net Cash Flow From Operating Activities, Continuing | $4.47M |
| Net Cash Flow From Investing Activities | -$1.05M |
| Net Cash Flow From Investing Activities, Continuing | -$1.05M |
| Net Cash Flow From Financing Activities | -$1.21M |
| Net Cash Flow From Financing Activities, Continuing | -$1.21M |
| Net Cash Flow | $2.21M |
| Net Cash Flow, Continuing | $2.21M |
| Comprehensive Income/Loss | -$545.40K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$545.40K |
| Other Comprehensive Income/Loss | $0.00 |